BY IDA JORGENSEN
-
Three health foundations invest in new initiative to combat third-leading global cause of death
The Novo Nordisk Structure, Gates Structure and Wellcome Trust fund are releasing a brand-new campaign to speed up the exploration of brand-new therapies for antimicrobial resistan…
-
New and different obesity biotech enters Nasdaq
Aadvark Rehabs revealed its strategies to go public in late January, and the firm is currently starting.
-
Advised by former Novo Nordisk boss: Biotech company turns weight-loss drug into robotic tablet
US-based Rani Rehabs, with guidance from a previous Novo Nordisk exec, has actually created a robot tablet computer that can provide semaglutide by mouth without squandering energe…
-
Biogen sells rights to phase 3 program for USD 250m
The program with the energetic component lithium filimab is presently being checked in stage 3 as a therapy for 2 various sorts of lupus.
-
Novo Nordisk struggles in hemophilia competition with Roche
The Danish pharmaceutical firm requires to relocate at a quicker rate if it is to take on Roche’s hit Hemlibra for more youthful people with hemophilia. However Novo Nordisk …
-
Novo Nordisk struggles in hemophilia competition with Roche
The Danish pharmaceutical company needs to move at a faster pace if it is to compete with Roche’s blockbuster Hemlibra for younger patients with hemophilia. But Novo Nordisk has on…
-
Novo Nordisk to apply for approval of Wegovy successor in 2026
The application for authorization of the brand-new weight-loss medicine will certainly be sent following brand-new stage 3 information anticipated throughout the initial quarter of…
-
Leo Pharma achieves positive results in phase 3 study of eczema cream for adolescents
Leo Pharma reveals favorable information from a Stage 3 research in people aged 12-17 years with delgocitinib, a lotion therapy for serious persistent hand dermatitis.
-
GN CEO’s pay package is largely unchanged
2024 was GN’s initial complete fiscal year after the merging of the Hearing and Sound departments, and hence Peter Karlströmer’s initial complete pay plan in the duty o…
-
Positive cash now flows as WSA CEO eyes more growth later this year
New launches will certainly drive development for the remainder of WS Audiology’s lean fiscal year and guide the firm in the direction of the objective of making even more ca…
